Engrams and Depressive Behaviors - Dana Walker
These two articles created a
narrative about memory engram-bearing cells and how they can manipulate fear and
depression-related behaviors. Ramirez’s 2013 article focused on creating false
memories by fear-conditioning mice in one context while recording which neurons
were active, then optically reactivating these neurons in a neutral, novel context.
Mice then associated this memory with a fearful context, such as a foot shock,
and formed a new fear memory. Ramirez’s 2015 article expanded on this finding.
They used this manipulation of memory engram cells to reactivate a positive
memory in stressed mice. Reactivation of positive memories, not neutral or
negative ones, helped increase struggle time and sucrose consumption, two
measures of depressive-like behavior. However, it didn’t affect anxiety-related
behavior. It was hypothesized that the BLA-NAc pathway was linked to this effect.
I appreciated the link between the
two articles and their potential implications for treating depression and anxiety.
However, I have trouble imagining how these results can be tested on or applied
to clinical populations. Animal testing is far different from human testing. It
would be very difficult to use optogenetics with humans in the same manner they
are used with mice. The procedures would have to be altered significantly, as
it is likely unethical to alter memories or implant optogenetic equipment in
human brains. Furthermore, the idea of “altering memories” has some scary implications
and could receive some backlash if applied to humans. Many things could go
wrong in the research process, or the end results could be used for the wrong
purposes. I believe the field has a long way to go in animal research before it
can begin to be considered for clinical phases, and even then, it will likely
have to undergo many changes to the protocol. Perhaps the best first step would
be to recruit participants with existing mental illnesses such as depression or
anxiety. They would think about an existing positive experience (instead of creating
one in the lab), which would be labeled for future use. Then, this memory could
be reactivated during a depressive episode see if the artificial recollection
is enough to improve symptoms.
Alternatively, Positive
Psychotherapy (PPT), mentioned as a reference in the 2015 article, could continue
to be a clinical alternative for these protocols. PPT, unlike other types of
therapy, revolves around positive experiences. Therefore, it could be a
valuable, non-invasive way to tell if recalling positive experiences can affect
depression- and anxiety-related behavior.
Comments
Post a Comment